# US 2025/0322975 A1 · Materials and processes for generating radioisotopes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0322975 A1
- Document ID: US20250322975A1
- Status: Published application
- Kind: A1
- Application number: 19/246,042
- Filed: 2025-06-23
- Published: 2025-10-16
- Earliest claimed: 2021-08-23
- Applicants: AdvanCell Isotopes Pty Limited
- Inventors: Julian Frederick KELLY
- Web page: https://patentgrep.com/patent/US20250322975A1

## CPC

- G21G 4/08: specially adapted for medical application (radiation therapy using radioactive sources A61N5/10)
- A61K 51/1289: {Devices or containers for impregnation, for emanation, e.g. bottles or jars for radioactive water for use in radiotherapy}
- C04B 35/495: based on vanadium, niobium, tantalum, molybdenum or tungsten oxides or solid solutions thereof with other oxides, e.g. vanadates, niobates, tantalates, molybdates or tungstates
- C04B 41/4535: {applied as a solution, emulsion, dispersion or suspension}
- C04B 41/4558: {Coating or impregnating involving the chemical conversion of an already applied layer, e.g. obtaining an oxide layer by oxidising an applied metal layer}
- C04B 41/5045: {Rare-earth oxides}
- C04B 41/87: Ceramics
- C25D 11/26: of refractory metals or alloys based thereon
- A61N 5/1001: {using radiation sources introduced into or applied onto the body; brachytherapy}
- G21G 2001/0094: {Other isotopes not provided for in the groups listed above}
- G21G: CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES (applications of radiation in general G21H5/00; handling particles, e.g. neutrons, or electromagnetic radiation not otherwise provided for G21K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C04B: LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE {(roofing granules E04D7/005)}; CERAMICS (devitrified glass-ceramics C03C10/00); REFRACTORIES; TREATMENT OF NATURAL STONE
- C25D: PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

The present disclosure generally relates to materials, processes, generators, and/or systems, for generating radioisotope. The present disclosure also generally relates to ceramic materials comprising radioisotope suitable for use in a radioisotope generator. The present disclosure also generally relates to processes, generators and/or systems, for producing and capturing radioisotope. The present disclosure also generally relates to the preparation of radioisotope solutions for use in radiopharmacy and/or other clinical applications.

## Claims

### Claim 1

A substrate for the generation of daughter radioisotopes, the substrate comprising:
a metal substrate; and
a tantalum oxide substrate disposed on a surface of the metal substrate,
wherein the tantalum oxide substrate has a porosity of less than 10% by volume.

### Claim 2 (depends on 1)

The substrate of claim 1, further comprising a parent radioisotope immobilized on or near a surface of the tantalum oxide substrate, wherein the tantalum oxide substrate is configured to allow the emanation of a gaseous radioisotope away from the surface of the tantalum oxide substrate.

### Claim 3 (depends on 2)

The substrate of claim 2, wherein the parent radioisotope is one or more solid compound phases that are crystalline.

### Claim 4 (depends on 2)

The substrate of claim 2, wherein the parent radioisotope is one more solid compound phases that are amorphous.

### Claim 5 (depends on 2)

The substrate of claim 2, wherein the parent radioisotope is one or more solid compound phases that are a combination of crystalline phases and amorphous phases.

### Claim 6 (depends on 2)

The substrate of claim 2, wherein the parent radioisotope comprises one or more of 228Th (Thorium-228) and 224Ra (Radium-224).

### Claim 7 (depends on 2)

The substrate of claim 2, wherein the daughter radioisotope has an average activity of at least 10 MBq per cm2.

### Claim 8 (depends on 2)

The substrate of claim 2, wherein the parent radioisotope has an average activity of at least 100 MBq per cm2.

### Claim 9 (depends on 1)

The substrate of claim 1, wherein the tantalum oxide substrate is formed by anodic polarization of the surface of the metal substrate.

### Claim 10 (depends on 1)

The substrate of claim 1, wherein the tantalum oxide substrate is substantially non-porous.

### Claim 11 (depends on 1)

The substrate of claim 1, wherein the substrate comprises one of a disk, plate, film, platen, slab, tube, tube-section, or monolith.

### Claim 12 (depends on 1)

The substrate of claim 1, wherein the tantalum oxide substrate is formed by thermal oxidation of the surface of the metal substrate.

### Claim 13 (depends on 1)

The substrate of claim 1, wherein the metal substrate comprises tantalum.
